Cardiac surgery represents a major branch of cardiothoracic surgical medicine dedicated to treating structural, vascular, and electrophysiological pathology of the heart. Utilizing specialized techniques such as cardiopulmonary bypass (heart-lung machine), surgeons can safely operate on a still, bloodless heart. Primary goals include revascularization of ischemic myocardium, repair or replacement of dysfunctional cardiac valves, and correction of congenital or acquired structural defects.

Pre-operative preparation involves baseline blood tests, electrocardiography, chest radiography, echocardiography, and coronary angiography. In the operating room, the patient receives general anesthesia and central venous and arterial monitoring. A median sternotomy or minimally invasive thoracotomy provides surgical access. Cardiopulmonary bypass is established via cannulation of the aorta and right atrium. Cold cardioplegia solution arrests the heart in diastole, providing a motionless field. The surgical procedure—such as graft anastomoses or valve replacement—is performed. After completion, the patient is gradually rewarmed, cardiac contraction resumes naturally or via defibrillation, and the patient is weaned off bypass. Chest tubes are inserted to drain fluid, and the sternum is closed with stainless steel wires before skin closure.

Evidence-based outcomes of cardiac surgery demonstrate substantial clinical benefits across multiple parameters. Coronary revascularization via CABG significantly improves long-term survival in multi-vessel CAD compared to medical management alone (ACC/AHA 2021 Guidelines). Valvular surgery restores normal intracardiac pressure gradients, alleviates heart failure symptoms, prevents irreversible myocardial remodeling, and reduces stroke risk associated with severe valvular lesions.

Recovery following cardiac surgery occurs over several months. The acute phase involves 1 to 2 days in the intensive care unit followed by 4 to 6 days in a telemetry unit. Sternal healing requires strict precautions for 6 to 8 weeks. Light activity resumes within 2 to 3 weeks, while complete recovery and return to full exertion typically require 12 weeks, supported by structured secondary prevention and phase II cardiac rehabilitation programs.

Cardiac surgery addresses a broad spectrum of cardiovascular disorders. Indications include severe coronary artery disease requiring coronary artery bypass grafting (CABG), valvular heart disease such as aortic stenosis or mitral regurgitation, thoracic aortic aneurysms and dissections, congenital heart defects, refractory heart failure necessitating mechanical circulatory support or transplantation, and cardiac arrhythmias like severe atrial fibrillation requiring surgical ablation.

Preparation for cardiac surgery requires comprehensive medical evaluation and lifestyle adjustments. Patients must stop antiplatelet or anticoagulant medications as directed by their surgical team, usually 3 to 7 days prior. Pre-operative testing includes complete blood count, kidney and liver function tests, coagulation studies, arterial blood gas, chest X-ray, ECG, and echocardiography. Smoking cessation is imperative at least 4 weeks before surgery to reduce pulmonary complications. Dental clearance is required to prevent surgical site endocarditis, particularly for valve procedures. Fasting begins at midnight prior to surgery, and patients wash with chlorhexidine soap to reduce skin bacterial flora.

Complications of cardiac surgery range from minor side effects to life-threatening events. Common risks include temporary atrial fibrillation, minor surgical site pain, and fatigue. Moderate risks include wound infection, pleural effusion, acute renal impairment, and postoperative anemia requiring transfusion. Rare but severe complications include perioperative stroke, myocardial infarction, major hemorrhage requiring re-operation, deep sternal wound infection (mediastinitis), multi-organ failure, and death. Risk scores such as the STS (Society of Thoracic Surgeons) risk model and EuroSCORE II are routinely used to quantify individual surgical risk based on baseline comorbidities.

The clinical cardiac surgery journey transitions through four distinct phases: pre-operative evaluation, intra-operative execution, critical care stabilization, and long-term cardiac rehabilitation. Pre-operatively, patients undergo diagnostic imaging, laboratory risk stratification, and optimization of comorbidities. Intra-operatively, procedures involve general anesthesia, surgical access, mechanical circulatory support, and defect repair. Post-operative recovery begins in an intensive care unit (ICU) before transitioning to a surgical ward, culminating in outpatient cardiac rehabilitation over 8 to 12 weeks.